The global urinary self-catheters market was valued at $1,722 million in 2018, and is projected to reach $2,387 million by 2026, registering a CAGR of 4.1% from 2019 to 2026.
A urinary catheter is a hollow, partially flexible tube, which is used to drain the urine when an individual is unable to do it naturally. These catheters consist of a drainage bag that assists to collect a urine. They are composed of silicone, PVC, or vinyl or red rubber latex.
The urinary self-catheter market is expected to exhibit significant market growth during the forecast period, owing to increase in prevalence of benign prostate hyperplasia (BPH), urinary incontinence, and spinal cord injuries; rise in number of surgeries, and increase in geriatric population. Upsurge in demand for hydrophilic intermittent catheters and favorable reimbursement policies for usage of urinary catheters further supplement the market growth.
Innovations in catheters, novel product launches, and rise in demand for intermittent catheters in emerging economies provide lucrative opportunities for the market expansion. However, the availability of substitutes of catheters and lack of awareness toward utilization of self-catheters hamper the market growth.
The global urinary self-catheters market is segmented based on product, type, application, and region. Depending on product, the market is bifurcated into intermittent catheters and external catheters. Intermittent catheters are further classified into uncoated intermittent catheters and coated intermittent catheters. Coated intermittent catheters are subsegmented into antimicrobial, hydrophilic, and others. According to type, the market is categorized into male type catheter and female type catheter. By application, it is divided into benign prostate hyperplasia (BPH), urinary incontinence, spinal cord injuries, and others. Region wise, it is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, Taiwan, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, Turkey, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
Intermittent Catheter
o Uncoated Intermittent Catheters
o Coated Intermittent Catheters
Antimicrobial Intermittent catheters
Hydrophilic Intermittent catheters
Others
External Catheter
Type
Male Type Catheter
Female Type Catheter
Application
Benign Prostate Hyperplasia (BPH)
Urinary Incontinence
Spinal Cord Injuries
Others
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Taiwan
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Turkey
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Asid Bonz GmbH
B Braun Melsungen AG
Becton Dickson and Company (C.R. Bard)
Boston Scientific Corporation
Coloplast A/S
ConvaTec
Hollister, Inc.
Medical Technologies of Georgia, Inc.
Medtronic plc.
Teleflex Incorporated
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Cure Medical
Pennine Healthcare
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. Key findings
2.2.1. Top investment pockets
2.2.2. Top impacting factors
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key forces shaping urinary self-catheter industry/market
3.3. Government regulations on global urinary self-catheter market
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in incidence of urinary disorders
3.4.1.2. Rise in geriatric population
3.4.1.3. Favorable reimbursement policies
3.4.1.4. Rise in adoption of hydrophilic catheters
3.4.1.5. Surge in healthcare expenditure worldwide
3.4.2. Restraints
3.4.2.1. Availability of alternatives to urinary self-catheters
3.4.2.2. Lack of awareness towards utilization of self-catheters
3.4.3. Opportunities
3.4.3.1. Emerging economies to offer lucrative opportunities
3.4.3.2. Innovations in urinary catheters and novel product launches
3.4.4. Impact analysis
CHAPTER 4: URINARY SELF-CATHETER MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast, by type
4.2. Intermittent catheters
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. Uncoated intermittent catheters
4.2.2.1.1. Market size and forecast
4.2.2.2. Coated intermittent catheters
4.2.2.2.1. Market size and forecast, by type
4.2.2.2.2. Antimicrobial intermittent catheters
4.2.2.2.2.1. Market size and forecast
4.2.2.2.3. Hydrophilic intermittent catheters
4.2.2.2.3.1. Market size and forecast
4.2.2.2.4. Other intermittent catheters
4.2.2.2.4.1. Market size and forecast, by type
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. External catheters
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
CHAPTER 5: URINARY SELF-CATHETER MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Male type catheter
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Female type catheter
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
CHAPTER 6: URINARY SELF-CATHETER MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Benign prostate hyperplasia (BPH)
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Urinary incontinence
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Spinal cord injuries
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Others
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
CHAPTER 7: URINARY SELF-CATHETER MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. urinary self-catheter market, by product type
7.2.2.1.2. U.S. urinary self-catheter market, by type
7.2.2.1.3. U.S. urinary self-catheter market, by application
7.2.2.2. Canada
7.2.2.2.1. Canada urinary self-catheter market, by product type
7.2.2.2.2. Canada urinary self-catheter market, by type
7.2.2.2.3. Canada urinary self-catheter market, by application
7.2.2.3. Mexico
7.2.2.3.1. Mexico urinary self-catheter market, by product type
7.2.2.3.2. Mexico urinary self-catheter market, by type
7.2.2.3.3. Mexico urinary self-catheter market, by application
7.2.3. North America market size and forecast, by product type
7.2.4. North America urinary self-catheter market, by type
7.2.5. North America urinary self-catheter market, by application
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany urinary self-catheter market, by product type
7.3.2.1.2. Germany urinary self-catheter market, by type
7.3.2.1.3. Germany urinary self-catheter market, by application
7.3.2.2. France
7.3.2.2.1. France urinary self-catheter market, by product type
7.3.2.2.2. France urinary self-catheter market, by type
7.3.2.2.3. France urinary self-catheter market, by application
7.3.2.3. UK
7.3.2.3.1. UK urinary self-catheter market, by product type
7.3.2.3.2. UK urinary self-catheter market, by type
7.3.2.3.3. UK urinary self-catheter market, by application
7.3.2.4. Italy
7.3.2.4.1. Italy urinary self-catheter market, by product type
7.3.2.4.2. Italy urinary self-catheter market, by type
7.3.2.4.3. Italy urinary self-catheter market, by application
7.3.2.5. Spain
7.3.2.5.1. Spain urinary self-catheter market, by product type
7.3.2.5.2. Spain urinary self-catheter market, by type
7.3.2.5.3. Spain urinary self-catheter market, by application
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe urinary self-catheter market, by product type
7.3.2.6.2. Rest of Europe urinary self-catheter market, by type
7.3.2.6.3. Rest of Europe urinary self-catheter market, by application
7.3.3. Europe market size and forecast, by product type
7.3.4. Europe urinary self-catheter market, by type
7.3.5. Europe urinary self-catheter market, by application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan urinary self-catheter market, by product type
7.4.2.1.2. Japan urinary self-catheter market, by type
7.4.2.1.3. Japan urinary self-catheter market, by application
7.4.2.2. China
7.4.2.2.1. China urinary self-catheter market, by product type
7.4.2.2.2. China urinary self-catheter market, by type
7.4.2.2.3. China urinary self-catheter market, by application
7.4.2.3. Australia
7.4.2.3.1. Australia urinary self-catheter market, by product type
7.4.2.3.2. Australia urinary self-catheter market, by type
7.4.2.3.3. Australia urinary self-catheter market, by application
7.4.2.4. India
7.4.2.4.1. India urinary self-catheter market, by product type
7.4.2.4.2. India urinary self-catheter market, by type
7.4.2.4.3. India urinary self-catheter market, by application
7.4.2.5. South Korea
7.4.2.5.1. South Korea urinary self-catheter market, by product type
7.4.2.5.2. South Korea urinary self-catheter market, by type
7.4.2.5.3. South Korea urinary self-catheter market, by application
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific urinary self-catheter market, by product type
7.4.2.6.2. Rest of Asia-Pacific urinary self-catheter market, by type
7.4.2.6.3. Rest of Asia-Pacific urinary self-catheter market, by application
7.4.3. Asia-Pacific Market size and forecast, by product type
7.4.4. Asia-Pacific urinary self-catheter market, by type
7.4.5. Asia-Pacific urinary self-catheter market, by application
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil urinary self-catheter market, by product type
7.5.2.1.2. Brazil urinary self-catheter market, by type
7.5.2.1.3. Brazil urinary self-catheter market, by application
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia urinary self-catheter market, by product type
7.5.2.2.2. Saudi Arabia urinary self-catheter market, by type
7.5.2.2.3. Saudi Arabia urinary self-catheter market, by application
7.5.2.3. South Africa
7.5.2.3.1. South Africa urinary self-catheter market, by product type
7.5.2.3.2. South Africa urinary self-catheter market, by type
7.5.2.3.3. South Africa urinary self-catheter market, by application
7.5.2.4. Turkey
7.5.2.4.1. Turkey urinary self-catheter market, by product type
7.5.2.4.2. Turkey urinary self-catheter market, by type
7.5.2.4.3. Turkey urinary self-catheter market, by application
7.5.2.5. Rest of LAMEA
7.5.2.5.1. Rest of LAMEA urinary self-catheter market, by product type
7.5.2.5.2. Rest of LAMEA urinary self-catheter market, by type
7.5.2.5.3. Rest of LAMEA urinary self-catheter market, by application
7.5.3. LAMEA Market size and forecast, by product type
7.5.4. LAMEA urinary self-catheter market, by type
7.5.5. LAMEA urinary self-catheter market, by application
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.1.1. Market player positioning, 2018
8.2. Competitive dashboard
8.3. Competitive heatmap
CHAPTER 9: COMPANY PROFILES
9.1. ASID BONZ GmbH
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Key strategic moves and developments
9.2. B BRAUN MELSUNGEN AG
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.3. BECTON, DICKINSON AND COMPANY (C.R. BARD)
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments
9.4. BOSTON SCIENTIFIC CORPORATION
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.5. COLOPLAST A/S
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. CONVATEC
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. HOLLISTER, INC.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Key strategic moves and developments
9.8. MEDTRONIC PLC.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.9. MEDICAL TECHNOLOGIES OF GEORGIA, INC.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.10. TELEFLEX INCORPORATED
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance